Tradestie Institutional Equity Comparison Engine

PTGX vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Momentum & Technical, Options & Structure while PTGX counters with relative strength in Growth & Margin. Fundamentally, PTGX trades at 36.9x Forward P/E with 58.6% operating margin (+5723.6% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, PTGX sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
PTGX 36.9x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner PTGX
Op Margin 58.6% vs 2.5% ยท YoY +5723.6% vs +54.9%
Momentum & Technical Winner AVDL
1Y +42.6% vs +138.1% ยท 52W Pos 53% vs 89%
Options & Structure Winner AVDL
CONSOLIDATION (16th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
PTGX NASDAQ
Protagonist Therapeutics, Inc
Pharmaceutical Preparations
$121.40
-2.11% 1D
Market Cap $8.1B
1M Return -12.99%
1Y Return +42.61%
Forward P/E 36.9x
Unified AI Score
44.6 / 100 HOLD
Tech 26.0 Fund 49.0 Flow 67.0 Mom 60.0
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTGX +42.61% AVDL +138.06% Spread: +4.39 pp (PTGX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PTGX TTM Op. Margin: 58.6% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PTGX vs AVDL. Trailing 12-month operating profitability (PTGX 58.6% vs AVDL 2.5%) and valuation multiples (PTGX 36.9x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTGX (5) vs AVDL (5)
Institutional Metric PTGX AVDL Criterion Row Winner
Market Capitalization Scale $8.1B $2.1B Larger Scale PTGX
Trailing P/E Ratio Valuation 26.2x 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation 36.9x 28.8x Lower Multiple AVDL
Revenue Growth (YoY) Growth +5723.6% +54.9% Higher Growth PTGX
Operating Margin (TTM) Profitability 58.6% 2.5% Higher Margin PTGX
Net Profit Margin Profitability 62.0% -0.1% Higher Margin PTGX
Return on Equity (ROE) Capital Efficiency 39.6% -0.3% Higher ROE PTGX
52-Week Range Position Momentum 53% ($77โ€“$161) 89% ($6โ€“$24) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.97ฮฒ ยท 36% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 44.6 / 100 (HOLD) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTGX vs AVDL Buy Guide
PTGX CONSOLIDATION
68d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live PTGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTGX nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.